Identification and prioritization of candidate genes for symptom variability in breast cancer survivors based on disease characteristics at the cellular level.
about
Genome-wide effects of MELK-inhibitor in triple-negative breast cancer cells indicate context-dependent response with p53 as a key determinant.Associations between pathologic tumor features and preadjuvant therapy cognitive performance in women diagnosed with breast cancer.An exploratory study of host polymorphisms in genes that clinically characterize breast cancer tumors and pretreatment cognitive performance in breast cancer survivors.Conducting Biobehavioral Research in Patients With Advanced Cancer: Recruitment Challenges and Solutions.Nuclear division cycle 80 promotes malignant progression and predicts clinical outcome in colorectal cancer.
P2860
Identification and prioritization of candidate genes for symptom variability in breast cancer survivors based on disease characteristics at the cellular level.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Identification and prioritizat ...... ristics at the cellular level.
@ast
Identification and prioritizat ...... ristics at the cellular level.
@en
type
label
Identification and prioritizat ...... ristics at the cellular level.
@ast
Identification and prioritizat ...... ristics at the cellular level.
@en
prefLabel
Identification and prioritizat ...... ristics at the cellular level.
@ast
Identification and prioritizat ...... ristics at the cellular level.
@en
P2860
P356
P1476
Identification and prioritizat ...... ristics at the cellular level.
@en
P2093
Theresa A Koleck
Yvette P Conley
P2860
P356
10.2147/BCTT.S88434
P577
2016-03-08T00:00:00Z